tiprankstipranks
Immunocore Holdings (IMCR)
NASDAQ:IMCR
US Market

Immunocore Holdings (IMCR) Income Statement

Compare
181 Followers

Immunocore Holdings Income Statement

Last quarter (Q3 2024), Immunocore Holdings's total revenue was $80.25M, an increase of 28.14% from the same quarter last year. In Q3, Immunocore Holdings's net income was $8.74M. See Immunocore Holdings’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 249.43M$ 143.74M$ 26.52M$ 30.11M$ 25.67M
Gross Profit
$ 248.39M$ 143.28M$ -46.71M$ -44.70M$ -74.32M
Operating Expenses
$ 308.04M$ 182.89M$ 161.68M$ 119.40M$ 144.17M
Depreciation and Amortization
$ 4.09M$ 5.33M$ 7.59M$ 8.98M$ 9.21M
EBITDA
$ -51.65M$ -38.35M$ -166.72M-$ -113.18M
Operating Income
$ -59.65M$ -39.61M$ -135.16M$ -86.19M$ -118.32M
Other Income/Expenses
$ -1.24M$ 5.79M$ 33.66M$ -1.17M$ -7.87M
Pretax Income
$ -60.89M$ -44.15M$ -140.93M$ -87.36M$ -126.19M
Net Income
$ -55.29M$ -41.22M$ -131.52M$ -74.09M$ -103.93M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -1.13$ -0.90$ -3.10$ -2.33$ -3.81
Diluted EPS
$ -1.13$ -0.90$ -3.00$ -2.33$ -3.81
Weighted Average Shares Outstanding
48.89M 45.71M 42.49M 31.78M 27.31M
Weighted Average Shares Outstanding (Diluted)
48.89M 45.71M 43.86M 31.78M 27.31M
Currency in USD

Immunocore Holdings Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis